Cell migration and wound-healing assays supported the invasive activity of osteosarcoma cells and downregulating SIRT1 with shRNA inhibition determined that the migration ability of osteosarcoma cells in vitro decreased. This evidence concerns the gene SIRT1 and osteosarcoma.